Gastrointestinal Tract Cancer and Diabetes Mellitus
Svačina Š.1, Matoulek M.1, Svobodová Š.1, Visokai V.2, Lipská L.2,Topolčan O.3, Zvárová J.4, Plavcová M.4
1III. interní klinika 1. lékařské fakulty UK a VFN, Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc. 2Chirurgická klinika 1. lékařské fakulty UK a Fakultní Thomayerovy nemocnice, Praha, přednosta MUDr. Vladimír Visokai 3I. interní klinika Lékařské fakulty UK a FN, Plzeň, přednosta doc. MUDr. Jan Filipovský, CSc. 4Evropské centrum pro medicínskou informatiku, statistiku a epidemiologii-Kardio, ředitelka prof. RNDr. Jana Zvárová, DrSc. |
|
Summary:
Risk of development of some gastrointestinal tract cancers (colorectal cancer, pancreas cancer
and liver cancer) is higher in type II diabetics. Another important risk factor is obesity (for gall
bladder cancer in women and in men also for stomach and esophageal cancer). Pathogenetic
factors have been explored especially in colorectal cancer (diet, hyperinsulinaemia, metabolic
receptors activation, absence of physical activity). Our Czech study also proved up to 4 times
increased risk of colorectal cancer in diabetics and, in accordance with literature, probable
influence of persistent diabetes on tumour development. Type II diabetes mellitus should be
considered as a risk factor especially for colorectal cancer, liver cancer, and pancreas cancer. In
type I diabetics no risk of gastrointestinal tract cancers was proved.
Key words:
Diabetes mellitus - Gastrointestinal tract tumours - Colorectal cancer - Metabolic
syndrome - Pancreas cancers - Obesity - Diet factors
|